Elsevier comments on its "fake" journals

A story that has receive extensive coverage over the past few weeks on the web is of a series of allegedly "fake" journals which were revealed during a court case in Australia concerning marketing of the drug Vioxx. There has been much coverage of this topic; one of the most recent is at Nature blogs, which includes a link to Elsevier's official comment yesterday on the "journals", which are described in the official comment as "a series of sponsored article compilation publications, on behalf of pharmaceutical clients, that were made to look like journals and lacked the proper disclosures". Michael Hansen, CEO of Elsevier's Health Sciences Division, noted that "We are currently conducting an internal review but believe this was an isolated practice from a past period in time. It does not reflect the way we operate today."